{"id":"https://openalex.org/W3009781639","doi":null,"title":"BASELINE CHARACTERISTICS OF THE FLUID STUDY PATIENTS: A RANDOMISED CLINICAL TRIAL INVESTIGATING THE NEED FOR COMPLETE RESOLUTION OF SUB-RETINAL FLUID (SRF) IN RANIBIZUMAB-TREATED PATIENTS WITH NEOVASCULAR AGE-RELATED MACULAR DEGENERATION (NAMD) USING A TREAT AND EXTEND (T&E) REGIMEN","display_name":"BASELINE CHARACTERISTICS OF THE FLUID STUDY PATIENTS: A RANDOMISED CLINICAL TRIAL INVESTIGATING THE NEED FOR COMPLETE RESOLUTION OF SUB-RETINAL FLUID (SRF) IN RANIBIZUMAB-TREATED PATIENTS WITH NEOVASCULAR AGE-RELATED MACULAR DEGENERATION (NAMD) USING A TREAT AND EXTEND (T&E) REGIMEN","publication_year":2015,"publication_date":"2015-01-01","ids":{"openalex":"https://openalex.org/W3009781639","mag":"3009781639"},"language":"en","primary_location":{"id":"mag:3009781639","doi":null,"is_oa":false,"landing_page_url":"https://findanexpert.unimelb.edu.au/scholarlywork/1016577-baseline-characteristics-of-the-fluid-study-patients--a-randomised-clinical-trial-investigating-the-need-for-complete-resolution-of-sub-retinal-fluid-(srf)-in-ranibizumab-treated-patients-with-neovascular-age-related-macular-degeneration-(namd)-using-a-treat-and-extend-(t&e)-regimen","pdf_url":null,"source":{"id":"https://openalex.org/S95018974","display_name":"Clinical and Experimental Ophthalmology","issn_l":"1442-6404","issn":["1442-6404","1442-9071"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-d","doyens","jufo-1","ki-jl-2","medline","norway-1","poland-100","russia-white-list-1"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":null,"license_id":null,"version":null,"is_accepted":false,"is_published":false,"raw_source_name":"Clinical and Experimental Ophthalmology","raw_type":null},"volume":null,"type":"article","is_traditional":true,"indexed_in":[],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5019510374","display_name":"Jennifer Arnold","orcid":"https://orcid.org/0000-0002-8065-9715","observed_orcids":["https://orcid.org/0000-0002-8065-9715"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Jennifer Arnold","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0002-8065-9715","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5109189652","display_name":"Caroline M. Markey","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Caroline M. Markey","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5101473901","display_name":"Paul Nigel Baird","orcid":"https://orcid.org/0000-0002-1305-3502","observed_orcids":["https://orcid.org/0000-0002-1305-3502"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Paul N. Baird","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0002-1305-3502","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5064377356","display_name":"Andrea Jane Richardson","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Andrea J. Richardson","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5077552328","display_name":"Nicol Kurstjens","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Nicol Kurstjens","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"last","author":{"id":"https://openalex.org/A5051997081","display_name":"Robyn H. Guymer","orcid":"https://orcid.org/0000-0002-9441-4356","observed_orcids":["https://orcid.org/0000-0002-9441-4356"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Robyn H. Guymer","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0002-9441-4356","affiliations":[]}],"institutions":[],"countries_distinct_count":0,"institutions_distinct_count":0,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":{"value":4150,"currency":"USD","value_usd":4150},"apc_paid":null,"fwci":0.0,"has_fulltext":false,"cited_by_count":1,"citation_normalized_percentile":{"value":0.43619519,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":88,"max":93},"biblio":{"volume":"43","issue":null,"first_page":null,"last_page":null},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10170","display_name":"Retinal Diseases and Treatments","score":0.9940999746322632,"subfield":{"id":"https://openalex.org/subfields/2731","display_name":"Ophthalmology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10170","display_name":"Retinal Diseases and Treatments","score":0.9940999746322632,"subfield":{"id":"https://openalex.org/subfields/2731","display_name":"Ophthalmology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11377","display_name":"Retinal and Macular Surgery","score":0.002199999988079071,"subfield":{"id":"https://openalex.org/subfields/2731","display_name":"Ophthalmology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11194","display_name":"Ocular Diseases and Beh\u00e7et\u2019s Syndrome","score":0.0006000000284984708,"subfield":{"id":"https://openalex.org/subfields/2731","display_name":"Ophthalmology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/subretinal-fluid","display_name":"subretinal fluid","score":0.9459999799728394},{"id":"https://openalex.org/keywords/neovascular-age-related-macular-degeneration","display_name":"neovascular age-related macular degeneration","score":0.9509999752044678},{"id":"https://openalex.org/keywords/ranibizumab","display_name":"ranibizumab","score":0.9990000128746033},{"id":"https://openalex.org/keywords/treat-and-extend-regimen","display_name":"treat-and-extend regimen","score":0.9100000262260437},{"id":"https://openalex.org/keywords/baseline-characteristics","display_name":"baseline characteristics","score":0.6990000009536743},{"id":"https://openalex.org/keywords/anti-vegf-therapy","display_name":"anti-VEGF therapy","score":0.9290000200271606}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.9613955616950989},{"id":"https://openalex.org/C2781100027","wikidata":"https://www.wikidata.org/wiki/Q414270","display_name":"Ranibizumab","level":4,"score":0.9599294066429138},{"id":"https://openalex.org/C2776403814","wikidata":"https://www.wikidata.org/wiki/Q27429789","display_name":"Macular degeneration","level":2,"score":0.9061310887336731},{"id":"https://openalex.org/C118487528","wikidata":"https://www.wikidata.org/wiki/Q161437","display_name":"Ophthalmology","level":1,"score":0.6648000478744507},{"id":"https://openalex.org/C535046627","wikidata":"https://www.wikidata.org/wiki/Q30612","display_name":"Clinical trial","level":2,"score":0.4813419282436371},{"id":"https://openalex.org/C2780827179","wikidata":"https://www.wikidata.org/wiki/Q422001","display_name":"Retinal","level":2,"score":0.4660189151763916},{"id":"https://openalex.org/C141071460","wikidata":"https://www.wikidata.org/wiki/Q40821","display_name":"Surgery","level":1,"score":0.28060024976730347},{"id":"https://openalex.org/C2777802072","wikidata":"https://www.wikidata.org/wiki/Q413299","display_name":"Bevacizumab","level":3,"score":0.22736194729804993},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.18185314536094666},{"id":"https://openalex.org/C2776694085","wikidata":"https://www.wikidata.org/wiki/Q974135","display_name":"Chemotherapy","level":2,"score":0.07047468423843384}],"mesh":[],"locations_count":1,"locations":[{"id":"mag:3009781639","doi":null,"is_oa":false,"landing_page_url":"https://findanexpert.unimelb.edu.au/scholarlywork/1016577-baseline-characteristics-of-the-fluid-study-patients--a-randomised-clinical-trial-investigating-the-need-for-complete-resolution-of-sub-retinal-fluid-(srf)-in-ranibizumab-treated-patients-with-neovascular-age-related-macular-degeneration-(namd)-using-a-treat-and-extend-(t&e)-regimen","pdf_url":null,"source":{"id":"https://openalex.org/S95018974","display_name":"Clinical and Experimental Ophthalmology","issn_l":"1442-6404","issn":["1442-6404","1442-9071"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-d","doyens","jufo-1","ki-jl-2","medline","norway-1","poland-100","russia-white-list-1"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":null,"license_id":null,"version":null,"is_accepted":false,"is_published":false,"raw_source_name":"Clinical and Experimental Ophthalmology","raw_type":null}],"best_oa_location":null,"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","score":0.9763000011444092,"display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2982448706","https://openalex.org/W2304396421","https://openalex.org/W7112919825","https://openalex.org/W2965769306","https://openalex.org/W3178642255","https://openalex.org/W3136819071","https://openalex.org/W3156160903","https://openalex.org/W7052335260","https://openalex.org/W935603760","https://openalex.org/W3178599262"],"abstract_inverted_index":null,"counts_by_year":[{"year":2020,"cited_by_count":1}],"updated_date":"2026-09-22T06:50:58.402377","created_date":"2020-03-13T00:00:00"}